Keyword: EuroBiotech Report
A top-line success against the pathological complete response rate endpoint in soft tissue sarcoma sent Nanobiotix’s stock up by more than 50%.
In this week's EuroBiotech Report, Freeline and iTeos reel in big rounds, Calliditas files for a $75 million IPO, Evotec snags Sanofi unit and more.
In our EuroBiotech roundup this week, BioLineRx presents OS data, Idorsia powers into phase 3 and GammaDelta names CMO.
Molecular Partners has rejigged its team, hiring Pamela Trail from Regeneron to serve as CSO and shunting Michael Stumpp across to the COO position.
The MPM Capital-led series B tees iTeos up to start dosing patients with an adenosine A2A antagonist later this year.
Syncona committed £85 million to Freeline, maintaining a big stake in a biotech that aims to redefine treatment of hemophilia B and Fabry disease.
The agreement sees Sanofi transfer 100 employees, more than 10 drug candidates and €60 million upfront to the German service provider.
In this week's EuroBiotech Report, U.K. creates £2.5 billion fund, AstraZeneca, Lilly hit by Alzheimer's flop, Complement lands Alexion deal and more.
In our EuroBiotech roundup this week, Syncona founds gene therapy startups, Vernalis cans Tris pact and Newron delays Rett readout.
The financing will set Calliditas up to start enrolling autoimmune kidney disease patients in a pivotal trial later this year.